Hydrogen saline treatment attenuates hyperoxia-induced retinopathy by inhibition of oxidative stress and reduction of VEGF expression.
Huang L, Zhao S, Zhang JH, Sun X · Ophthalmic research · 2012
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
Molecular hydrogen produced a favorable primary result in this animal study, supporting further research into its potential for oxidative stress and antioxidant signaling.
Hydrogen-rich saline oxidative stress study 2012: what the findings mean
This H2HUBB page translates the technical study record into consumer-friendly language while preserving the scientific details. This animal study examined Hydrogen saline treatment attenuates hyperoxia-induced retinopathy by inhibition of oxidative stress (an imbalance in which reactive molecules exceed the body’s ability to control them) and reduction of VEGF expression. The abstract describes Mouse model; hydrogen delivered as hydrogen-rich saline and injected or infused hydrogen; reported duration 5 days. Hydrogen saline may be a potential treatment for hyperoxia-induced retinopathy that acts via the inhibition of oxidative stress and the reduction of VEGF expression.
Publication: Huang L, Zhao S, Zhang JH, Sun X, Ophthalmic research, 2012.
What the researchers studied
Retinal neovascularization or retinopathy is a proliferative disorder of the retinal capillaries and is the primary cause of blindness. Some studies have shown that…
What effects did molecular hydrogen have?
Observed hydrogen effects: Hydrogen saline may be a potential treatment for hyperoxia-induced retinopathy that acts via the inhibition of oxidative stress (an imbalance in which reactive molecules exceed the body’s ability to control them) and the reduction of VEGF expression. Previous reports have indicated that hydrogen has a therapeutic, antioxidant activity by selectively reducing hydroxyl radicals.
Why these findings matter
The result supports the biological and therapeutic potential of hydrogen-rich saline for oxidative stress and antioxidant signaling. It shows that hydrogen affected meaningful outcomes in an animal model, but it does not prove that the same benefit will occur in people.
How strong is this evidence?
This is preclinical animal evidence. It can show biological effects in a whole living system, but human effectiveness and dosing still require clinical trials.
Technical study details
- Publication type: Animal study
- Evidence type: Preclinical animal evidence
- Research model or population: Mouse model
- Hydrogen method: Hydrogen-rich saline
- Dose or treatment amount: 5 ml
- Treatment duration: 5 days
Limitations and safety
Important limitations: Preclinical animal findings may not translate directly to human outcomes. The intervention or follow-up period appears relatively short.
Safety information: The abstract did not provide detailed safety or adverse-event information.
Original study and H2HUBB research context
This page explains a published research record and does not turn one study into a medical recommendation. Read the original scientific source for the complete methods, statistics, and author conclusions. Compare this result with related evidence in the H2HUBB Molecular Hydrogen Research Library.